Compare Stocks: CRMD, PBH, BHC, and PRGO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BHC Bausch Health Cos	$5.93 +0.6%	$6.16	$4.33 ▼ $8.00	$2.22B	0.37	2.49 million shs	809,279 shs
CRMD CorMedix	$7.29 -1.4%	$7.85	$6.13 ▼ $13.02	$567.79M	1.4	1.58 million shs	283,411 shs
PBH Prestige Consumer Healthcare	$48.95 +0.9%	$49.47	$42.62 ▼ $71.07	$2.32B	0.34	559,190 shs	112,493 shs
PRGO Perrigo	$15.97 +3.9%	$14.07	$9.23 ▼ $22.02	$2.22B	0.69	3.08 million shs	2.74 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BHC Bausch Health Cos	-0.68%	-2.18%	+0.51%	+20.47%	-4.23%
CRMD CorMedix	-0.94%	+1.51%	-5.50%	-12.23%	-30.15%
PBH Prestige Consumer Healthcare	-0.77%	+4.14%	+3.21%	+0.16%	-21.55%
PRGO Perrigo	-0.66%	+9.55%	+12.38%	+51.36%	-27.67%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BHC Bausch Health Cos	$5.93 +0.6%	$6.16	$4.33 ▼ $8.00	$2.22B	0.37	2.49 million shs	809,279 shs
CRMD CorMedix	$7.29 -1.4%	$7.85	$6.13 ▼ $13.02	$567.79M	1.4	1.58 million shs	283,411 shs
PBH Prestige Consumer Healthcare	$48.95 +0.9%	$49.47	$42.62 ▼ $71.07	$2.32B	0.34	559,190 shs	112,493 shs
PRGO Perrigo	$15.97 +3.9%	$14.07	$9.23 ▼ $22.02	$2.22B	0.69	3.08 million shs	2.74 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BHC Bausch Health Cos	-0.68%	-2.18%	+0.51%	+20.47%	-4.23%
CRMD CorMedix	-0.94%	+1.51%	-5.50%	-12.23%	-30.15%
PBH Prestige Consumer Healthcare	-0.77%	+4.14%	+3.21%	+0.16%	-21.55%
PRGO Perrigo	-0.66%	+9.55%	+12.38%	+51.36%	-27.67%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BHC Bausch Health Cos	2.14	Hold	$8.00	35.02% Upside
CRMD CorMedix	2.78	Moderate Buy	$15.00	105.90% Upside
PBH Prestige Consumer Healthcare	2.40	Hold	$67.67	38.24% Upside
PRGO Perrigo	2.00	Hold	$19.33	21.06% Upside

Current Analyst Ratings Breakdown

Latest CRMD, PBH, BHC, and PRGO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/8/2026	CRMD CorMedix	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C) ➝ Hold (C+)
10/8/2026	BHC Bausch Health Cos	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sector Perform	$9.00
9/30/2026	PBH Prestige Consumer Healthcare	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Strong-Buy
9/23/2026	CRMD CorMedix	Oppenheimer Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Outperform	$15.00
9/22/2026	PBH Prestige Consumer Healthcare	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D+)
9/21/2026	BHC Bausch Health Cos	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Strong-Buy
8/20/2026	BHC Bausch Health Cos	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong Sell ➝ Hold
8/14/2026	CRMD CorMedix	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Outperform	$13.00 ➝ $14.00
8/11/2026	CRMD CorMedix	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Hold (C)
8/10/2026	PBH Prestige Consumer Healthcare	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong Sell ➝ Hold
8/6/2026	PRGO Perrigo	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D-) ➝ Sell (D)

(Data available from 10/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BHC Bausch Health Cos	$10.27B	0.22	$7.31 per share	0.81	$1.02 per share	5.81
CRMD CorMedix	$311.71M	1.82	$2.00 per share	3.65	$5.14 per share	1.42
PBH Prestige Consumer Healthcare	$1.09B	2.13	$5.20 per share	9.41	$39.89 per share	1.23
PRGO Perrigo	$4.25B	0.52	$5.47 per share	2.92	$21.33 per share	0.75

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BHC Bausch Health Cos	$157M	-$2.96	N/A	1.47	N/A	-10.12%	-561.95%	6.31%	10/28/2026 (Estimated)
CRMD CorMedix	$163.05M	$2.14	3.40	52.04	1.38	40.49%	40.52%	20.61%	11/11/2026 (Estimated)
PBH Prestige Consumer Healthcare	$190.30M	$3.57	13.72	9.62	1.54	15.57%	11.39%	5.66%	11/5/2026 (Estimated)
PRGO Perrigo	-$1.43B	-$12.51	N/A	6.77	1.77	-41.85%	11.25%	4.08%	11/4/2026 (Estimated)

Latest CRMD, PBH, BHC, and PRGO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/11/2026	Q3 2026	CRMD CorMedix	-$0.1050	N/A	N/A	N/A	$53.23 million	N/A
11/5/2026	Q2 2027	PBH Prestige Consumer Healthcare	$1.07	N/A	N/A	N/A	$329.15 million	N/A
11/4/2026	Q3 2026	PRGO Perrigo	$0.5170	N/A	N/A	N/A	$991.53 million	N/A
10/28/2026	Q3 2026	BHC Bausch Health Cos	$1.25	N/A	N/A	N/A	$2.72 billion	N/A
8/13/2026	Q2 2026	CRMD CorMedix	$0.2380	$0.29	+$0.0520	$0.29	$96.04 million	$101.93 million
8/6/2026	Q1 2027	PBH Prestige Consumer Healthcare	$0.8940	$0.98	+$0.0860	$0.61	$253.02 million	$265.71 million
8/5/2026	Q2 2026	PRGO Perrigo	$0.3880	$0.50	+$0.1120	$0.53	$1.02 billion	$1.02 billion
7/29/2026	Q2 2026	BHC Bausch Health Cos	$0.96	$1.26	+$0.30	$0.68	$2.59 billion	$2.83 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BHC Bausch Health Cos	N/A	N/A	N/A	N/A	N/A
CRMD CorMedix	N/A	N/A	N/A	N/A	N/A
PBH Prestige Consumer Healthcare	N/A	N/A	N/A	N/A	N/A
PRGO Perrigo	$1.16	7.26%	+5.21%	N/A	23 Years

Latest CRMD, PBH, BHC, and PRGO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2026	PRGO Perrigo	quarterly	$0.29	7.98%	8/28/2026	8/28/2026	9/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BHC Bausch Health Cos	N/A	1.44	1.08
CRMD CorMedix	0.31	2.56	2.36
PBH Prestige Consumer Healthcare	1.06	3.23	1.99
PRGO Perrigo	1.31	2.32	1.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BHC Bausch Health Cos	78.65%
CRMD CorMedix	34.18%
PBH Prestige Consumer Healthcare	99.95%
PRGO Perrigo	95.91%

Insider Ownership

Company	Insider Ownership
BHC Bausch Health Cos	20.67%
CRMD CorMedix	3.50%
PBH Prestige Consumer Healthcare	1.50%
PRGO Perrigo	0.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BHC Bausch Health Cos	20,300	374.38 million	297.00 million	Optionable
CRMD CorMedix	191	77.94 million	75.22 million	Optionable
PBH Prestige Consumer Healthcare	890	47.38 million	46.66 million	Optionable
PRGO Perrigo	8,100	138.77 million	138.21 million	Optionable

CRMD, PBH, BHC, and PRGO Headlines

Recent News About These Companies

Perrigo to pay $10 million to settle US class action over baby formula prices

6 minutes ago | reuters.com

Perrigo Company plc (NYSE:PRGO) Stock Rated "Hold" by Sell-Side Analysts

October 13 at 10:13 AM | marketbeat.com

Critical Contrast: Perrigo (NYSE:PRGO) & Ovid Therapeutics (NASDAQ:OVID)

October 13 at 8:17 AM | americanbankingnews.com

Perrigo: Cheap Valuation Overshadowed By Heavy Debt

October 13 at 4:30 AM | seekingalpha.com

Perrigo Co PLC (PRGO) Stock Up 3.9% and Still Undervalued -- GF Score: 60/100

October 9, 2026 | gurufocus.com

Perrigo may have attracted takeover interest - Betaville

October 9, 2026 | seekingalpha.com

Perrigo Company plc $PRGO Shares Bought by O Keefe Stevens Advisory Inc.

October 9, 2026 | marketbeat.com

Perrigo (NYSE:PRGO) Stock Moved Down to Buy by Wall Street Zen

September 27, 2026 | marketbeat.com

Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?

September 25, 2026 | zacks.com

Squarepoint Ops LLC Cuts Position in Perrigo Company plc $PRGO

September 25, 2026 | marketbeat.com

Perrigo (NYSE:PRGO) Stock Price Up 5.9% - Should You Buy?

September 24, 2026 | marketbeat.com

Perrigo (NYSE:PRGO) Upgraded at Wall Street Zen

September 19, 2026 | marketbeat.com

Perrigo Company plc (NYSE:PRGO) Receives Consensus Rating of "Hold" from Analysts

September 18, 2026 | marketbeat.com

Perrigo (PRGO) Up 13.8% Since Last Earnings Report: Can It Continue?

September 4, 2026 | zacks.com

Perrigo to Attend the Barclays Global Consumer Conference

August 27, 2026 | prnewswire.com

PRGO or NEOG: Which Is the Better Value Stock Right Now?

August 26, 2026 | zacks.com

Should Value Investors Buy Perrigo (PRGO) Stock?

August 26, 2026 | zacks.com

Perrigo Company plc

August 24, 2026 | money.usnews.com

This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.

August 22, 2026 | fool.com

Perrigo Co. PLC stock underperforms Tuesday when compared to competitors despite daily gains

August 19, 2026 | marketwatch.com

Perrigo Earnings Call Balances Pressure and Progress

August 16, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRMD, PBH, BHC, and PRGO Company Descriptions

Bausch Health Cos NYSE:BHC

$5.92 +0.04 (+0.59%)

As of 12:44 PM Eastern

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

CorMedix NASDAQ:CRMD

$7.28 -0.11 (-1.42%)

As of 12:44 PM Eastern

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Prestige Consumer Healthcare NYSE:PBH

$48.95 +0.45 (+0.93%)

As of 12:44 PM Eastern

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Perrigo NYSE:PRGO

$15.97 +0.60 (+3.90%)

As of 12:44 PM Eastern

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CRMD, PBH, BHC, and PRGO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CRMD, PBH, BHC, and PRGO Earnings

Compare Dividends

Latest CRMD, PBH, BHC, and PRGO Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CRMD, PBH, BHC, and PRGO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRMD, PBH, BHC, and PRGO Company Descriptions

Bausch Health Cos NYSE:BHC

CorMedix NASDAQ:CRMD

Prestige Consumer Healthcare NYSE:PBH

Perrigo NYSE:PRGO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CRMD, PBH, BHC, and PRGO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CRMD, PBH, BHC, and PRGO Earnings

Compare Dividends

Latest CRMD, PBH, BHC, and PRGO Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CRMD, PBH, BHC, and PRGO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRMD, PBH, BHC, and PRGO Company Descriptions

Bausch Health Cos NYSE:BHC

CorMedix NASDAQ:CRMD

Prestige Consumer Healthcare NYSE:PBH

Perrigo NYSE:PRGO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools